Product
Iron Sucrose
Aliases
Iron sucrose, Venofer
Name
Venofer
INN Name
iron sucrose
FDA Approved
Yes
5 clinical trials
2 organizations
7 indications
1 document
Indication
Iron DeficiencyIndication
AnaemiaIndication
Chronic Kidney DiseaseIndication
Iron Deficiency AnemiaIndication
Patient Blood ManagementIndication
Cardiac surgeryIndication
Iron Deficiency Anemia in ChildbirthClinical trial
Ferumoxytol Compared to Iron Sucrose Trial (FIRST): A Randomized, Multicenter, Trial of Ferumoxytol Compared to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney DiseaseStatus: Completed, Estimated PCD: 2011-07-19
Clinical trial
A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)Status: Recruiting, Estimated PCD: 2023-08-31
Clinical trial
Evaluation of the Effect of Lactoferrin Versus Intravenous Iron Sucrose in Treatment of Iron Deficiency Anemia During PregnancyStatus: Not yet recruiting, Estimated PCD: 2024-01-01
Clinical trial
Effectiveness of Iron Sucrose Combined With rHuEPO and Ascorbic Acid in Improving Perioperative Anaemia in Patients Undergoing Major Cardiac SurgeryStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Iron Administration Via Colonic Transendoscopic Enteral Tubing Combined With Washed Microbiota Transplantation for Iron Deficiency:A Double-blind Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2026-01-01
Document
DailyMed Label: VenoferOrganization
A-S Medication SolutionsOrganization
Fresenius Medical Care Holdings, Inc.